New study: Montreal researchers identify three drugs that could reduce mortality in severely ill COVID-19 patients
Researchers from the RI-MUHC and the 91ÉçÇø Genome Centre examine differences in ICU patients who recovered or died from COVID-19 and identify candidate drugs to treat severe…
The dazzling potential of RNA therapies
Billions of people around the world have now received a Moderna or BioNTech-Pfizer COVID-19 vaccine. Created with synthetically developed messenger ribonucleic acid (mRNA) that…
91ÉçÇø joins Moderna in battle against global health threats
91ÉçÇø is the first university in Canada to join the global platform that will accelerate the development of and expand the impact of mRNA vaccines and medicines 91ÉçÇø…
Similar to editing a film, mRNA splicing allows cancer cells to change the narrative
Researchers identify mechanism that offers potential to new therapeutic avenues 91ÉçÇø researchers are part of a new study led by the University of California, San Francisco (UCSF)…
Researchers unlock mysteries of complex microRNA oncogenes
New research led by 91ÉçÇø’s Goodman Cancer Research Centre improves our understanding of microRNAs MicroRNAs are tiny molecules of nucleic acid that control gene expression…